Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft

Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft

Anumita Chaudhury1, Surajit Das1, Ralph M Bunte2, Gigi NC Chiu11Department of Pharmacy, Faculty of Science, National University of Singapore, 2Duke-NUS Graduate Medical School, Singapore, Republic of SingaporeAbstract: Intraperitoneal (IP) therapy with platinum (Pt)-based drugs has shown promising r...

Full description

Bibliographic Details
Main Authors:	Bunte RM, Das S, Chaudhury A, Chiu GNC
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-02-01
Series:	International Journal of Nanomedicine
Online Access:	http://www.dovepress.com/potent-therapeutic-activity-of-folate-receptor-targeted-liposomal-carb-a9260

Similar Items

Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin
by: Maurie Markman
Published: (2009-02-01)

The effect of consolidation treatment with intraperitoneal carboplatin in advanced epithelial ovarian cancers
by: Azamsadat Mousavi, et al.
Published: (2014-07-01)

Folate receptor targeting of radiolabeled liposomes reduces intratumoral liposome accumulation in human KB carcinoma xenografts
by: Christensen E, et al.
Published: (2018-11-01)

Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer
by: Xiangbin Tan, et al.
Published: (2023-09-01)

Comparison of Efficacy and Safety Between Liposome-paclitaxel plus Carboplatin and Paclitaxel plus Carboplatin on Epithelial Ovarian Cancer
by: HOU Wenjie, et al.
Published: (2018-06-01)

Comparison of Neoadjuvant Chemotherapy Efficiency in Advanced Ovarian Cancer Patients Treated With Paclitaxel Plus Carboplatin and Intraperitoneal Bevacizumab vs. Paclitaxel With Carboplatin
by: Yin Tao, et al.
Published: (2022-03-01)

Investigation of Characteristics and Behavior of Loaded Carboplatin on the, Liposomes Nanoparticles, on the Lung and Ovarian Cancer: An In-Vitro Evaluation
by: Majid Hasanzadegan Roudsari, et al.
Published: (2016-04-01)

Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma
by: Mohsen Ghaferi, et al.
Published: (2022-10-01)

Combined Interval Cytoreductive Surgery and Carboplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Advanced Primary High-Grade Serous Ovarian Cancer
by: Claudèle Brault, et al.
Published: (2023-12-01)

Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery
by: Sally Mullany, et al.
Published: (2020-11-01)

Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
by: Demuytere J, et al.
Published: (2024-01-01)

A novel salt inducible kinase 2 inhibitor, ARN-3261, sensitizes ovarian cancer cell lines and xenografts to carboplatin
by: Fan, D, et al.
Published: (2021)

A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin
by: Dengxuan Fan, et al.
Published: (2021-01-01)

Imaging of treatment response to the combination of carboplatin and paclitaxel in human ovarian cancer xenograft tumors in mice using FDG and FLT PET.
by: Mette Munk Jensen, et al.
Published: (2013-01-01)

Effect of Cerenkov Radiation-Induced Photodynamic Therapy with <sup>18</sup>F-FDG in an Intraperitoneal Xenograft Mouse Model of Ovarian Cancer
by: Yi-An Chen, et al.
Published: (2021-05-01)

Therapeutic strategies targeting folate receptor α for ovarian cancer
by: Jia Mai, et al.
Published: (2023-08-01)

Folate Receptor Targeted Photodynamic Therapy: A Novel Way to Stimulate Anti-Tumor Immune Response in Intraperitoneal Ovarian Cancer
by: Martha Baydoun, et al.
Published: (2023-07-01)

Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
by: Sevgi Ayhan, et al.
Published: (2023-09-01)

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
by: Miguel Martin, et al.
Published: (2021-03-01)

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study
by: Briasoulis Evangelos, et al.
Published: (2010-01-01)

Formulation Strategies for Folate-Targeted Liposomes and Their Biomedical Applications
by: Parveen Kumar, et al.
Published: (2019-08-01)

Enzymatic synthesis and in vitro evaluation of folate-functionalized liposomes
by: Guo B, et al.
Published: (2017-06-01)

Corrigendum: Therapeutic strategies targeting folate receptor α for ovarian cancer
by: Jia Mai, et al.
Published: (2024-04-01)

Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer
by: Sandrine Barbier, et al.
Published: (2023-01-01)

Molecular Biology of Ovarian Cancer: From Mechanisms of Intraperitoneal Metastasis to Therapeutic Opportunities
by: Krzysztof Książek
Published: (2021-04-01)

Functional coating of liposomes using a folate&ndash;polymer conjugate to target folate receptors
by: Watanabe K, et al.
Published: (2012-07-01)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
by: McKayla J. Riggs, et al.
Published: (2020-01-01)

Estrone-Conjugated PEGylated Liposome Co-Loaded Paclitaxel and Carboplatin Improve Anti-Tumor Efficacy in Ovarian Cancer and Reduce Acute Toxicity of Chemo-Drugs
by: Tang H, et al.
Published: (2022-07-01)

Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B
by: Yuanyu Huang, et al.
Published: (2022-02-01)

Limitations to the use of carboplatin-based therapy in advanced ovarian cancer
by: Christina Fotopoulou
Published: (2014-12-01)

Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging
by: Ding N, et al.
Published: (2011-10-01)

Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients
by: Zhenhua Du, et al.
Published: (2015-07-01)

Improving intraperitoneal adenovirus virotherapy for ovarian cancer
by: Thoma, CMM
Published: (2011)

Targeting gene therapy to intraperitoneal ovarian carcinoma
by: Morrison, J
Published: (2006)

Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer
by: Stig Palm, et al.
Published: (2021-01-01)

Exploiting the synergy between carboplatin and ABT-737 in the treatment of ovarian carcinomas
by: Jain, H, et al.
Published: (2012)

Analysis of the toxicity induced by carboplatin and paclitaxel regimen in ovarian cancer patients
by: Thaís A. GOUVÊA, et al.
Published: (2022-09-01)

Exploiting the synergy between carboplatin and ABT-737 in the treatment of ovarian carcinomas.
by: Harsh Vardhan Jain, et al.
Published: (2014-01-01)

Successful avatrombopag combined with cyclosporine treatment for carboplatin/pegylated liposomal doxorubicin/bevacizumab-induced acquired amegakaryocytic thrombocytopenia in a patient with recurrent ovarian cancer: case report
by: Weikang Meng, et al.
Published: (2024-02-01)

A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma.
by: Md Sazzad Hassan, et al.
Published: (2017-01-01)